Skip to main content

Table 3 Clinical Effectiveness

From: Evaluating the feasibility of implementing a Telesleep pilot program using two-tiered external facilitation

Clinical Outcome MeasuresTelesleep Remote Monitoring
N = 38
Usual Care Control
N = 52
P-value
30-Day Measures
 Median Hours Used per Night (hours): Mean ± standard deviation
(range)
4.6 ± 2.5
(0.02–8.8)
4.2 ± 2.8
(0.0–9.4)
0.486
 Residual AHI (events/h):a Mean ± standard deviation
(range)
3.2 ± 3.8
(0.0–18.1)
4.4 ± 7.1
(0.0–35.2)
0.347
 Residual AHI < 5 events/h: % (n)81.6% (31)82.7% (43)1.000
90-Day Measures
 Median Hours Used per Night (hours): Mean ± standard deviation
(range)
4.6 ± 2.4
(0.02–8.9)
4.1 ± 2.6
(0.0–8.6)
0.355
 Residual AHI (events/h): Mean (range)2.8 ± 2.6
(0.0–10.3)
3.6 ± 4.9
(0.0–30.3)
0.362
 Residual AHI < 5 events/h: % (n)81.6% (31)84.6% (44)0.778
180-Day Measures
 Median Hours Used per Night (hours): Mean ± standard deviation
(range)
4.6 ± 2.5
(0.06–9.07)
4.0 ± 2.7
(0.0–9.13)
0.286
 Residual AHI (events/h): Mean ± standard deviation
(range)
2.6 ± 2.5
(0.0–10.1)
3.6 ± 5.4
(0.0–34.3)
0.292
 Residual AHI < 5 events/h: % (n)86.8% (33)82.7% (43)0.770
 Adherent (≥4 h/night for > 70% of nights)32% (12)23% (12)0.470
 Non-Adherent (< 4 h/night for < 70% of nights)68% (26)77% (40)
 Adherent and disease control (Residual AHI < 5 events/h)32% (12)21% (11)0.330
  1. aResidual AHI refers to the apnea hypopnea index recorded by the positive airway pressure (PAP) machine and denotes the degree to which the PAP eliminates respiratory events during sleep